ClinicalTrials.gov
ClinicalTrials.gov Menu

Group Counseling for Smoking Cessation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00104481
Recruitment Status : Completed
First Posted : March 2, 2005
Last Update Posted : December 8, 2011
Sponsor:
Information provided by:
American University

Brief Summary:
The purpose of this study is to evaluate the effectiveness of group therapy for cigarette smoking cessation. The group meets for 8 sessions and includes education and group discussion about the effects of smoking and ways to cope with withdrawal symptoms and other challenges to maintaining abstinence. In one condition, the groups also learn techniques based on cognitive therapy, to help cope with negative feelings.

Condition or disease Intervention/treatment Phase
Smoking Behavioral: cognitive behavior therapy Phase 1 Phase 2

Detailed Description:

The comparison condition is the same length as the cognitive behavior therapy condition but omits the cognitive restructuring component. In both conditions, smokers prepare for a quit date by using scheduled reduced smoking, which involves smoking on a set schedule that gradually reduces the number of cigarettes smoked. Post-treatment assessments occur one week after the end of treatment, and at 3-month followup.

Pre- and post-treatment assessments include measures of coping skills and emotional acceptance, as well as smoking rate.


Study Type : Interventional  (Clinical Trial)
Enrollment : 240 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Cognitive Behavior Therapy for Smoking Cessation
Study Start Date : January 2005
Study Completion Date : August 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. cigarette smoking abstinence

Secondary Outcome Measures :
  1. cognitive coping skills
  2. depressive symptoms
  3. acceptance
  4. distress tolerance


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Regular daily smokers interested in quitting

Exclusion Criteria:

  • Significant suicidal ideation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00104481


Locations
United States, District of Columbia
American University
Washington, District of Columbia, United States, 20016-8062
Sponsors and Collaborators
American University
Investigators
Principal Investigator: David A Haaga, Ph.D. American University

Publications:
ClinicalTrials.gov Identifier: NCT00104481     History of Changes
Other Study ID Numbers: 2R15CA077732-02A1 ( U.S. NIH Grant/Contract )
First Posted: March 2, 2005    Key Record Dates
Last Update Posted: December 8, 2011
Last Verified: March 2007

Keywords provided by American University:
cognitive behavior therapy
coping
smoking cessation
acceptance
expectancies
quit smoking
quitting smoking